INTRODUCTION {#s1}
============

Moebius syndrome was first described in the 1880s by Moebius and von Graefe, with cardinal features of facial and abducens nerve palsies ([@PATELMCS000984C25]; [@PATELMCS000984C45]). Subsequently, additional clinical features were recognized within the diagnostic spectrum, including other cranial nerve (CN) defects, orofacial malformations, and skeletal abnormalities such as limb defects and chest wall abnormalities ([@PATELMCS000984C36]; [@PATELMCS000984C46]; [@PATELMCS000984C37]). [@PATELMCS000984C38] studied 25 Swedish individuals with Moebius syndrome and reported abnormalities of abducens and facial nerve involvement in all the affected individuals (100%). Speech was impaired in 17/22 (77%) patients, and malformations of the tongue including tongue atrophy, impaired motility, and/or hypoglossal nerve involvement occurred in about two-thirds of cases. Limb malformations were seen in 10/25 (40%) individuals, such as talipes equinovarus deformity, syndactyly, and oligodactyly. Poland anomaly was noted in 2/25 cases. Periodontal disease was observed frequently in the patients because of impaired motility of facial and tongue muscles. Less frequent abnormalities included cleft lip/palate and sensorineural hearing loss.

Several features associated with Moebius syndrome are considered to derive from abnormal development of the rhombencephalon or hindbrain, which develops into the medulla, pons, and cerebellum ([@PATELMCS000984C44]). Although the pathogenesis remains unknown, an intrauterine vascular event linked to subclavian artery disruption or a toxic injury in the critical period during the first trimester has been proposed ([@PATELMCS000984C10]). Misoprostol, thalidomide, and maternal cocaine exposure have all been implicated in vascular events affecting the sixth and seventh cranial nerves and limb defects ([@PATELMCS000984C14]; [@PATELMCS000984C28]; [@PATELMCS000984C24]). In most cases, Moebius syndrome occurs as an isolated event. Autosomal dominant transmission in rare pedigrees ([@PATELMCS000984C18]; [@PATELMCS000984C9]; [@PATELMCS000984C30]; [@PATELMCS000984C43]) and chromosomal abnormalities reported in singleton and familial cases ([@PATELMCS000984C47]; [@PATELMCS000984C35]; [@PATELMCS000984C3]) imply genetic factors that likely contribute to disease causation. [@PATELMCS000984C23] reported clinical findings in 31 affected individuals and concluded that, in cases with combined cranial nerve palsies and skeletal abnormalities, no familial transmission was observed. On the contrary, a mother and son were reported to have facial and ocular involvement with skeletal features ([@PATELMCS000984C12]). These examples highlight the clinical variability, potentially reflecting genetic heterogeneity in this disorder.

Several genetic loci have been implicated in Moebius syndrome based on cytogenetic anomalies described in rare families. A reciprocal translocation t(1;13)(p34;q13) was reported to segregate with congenital facial diplegia and flexion contractures of the fingers in multiple affected members spanning three generations ([@PATELMCS000984C47]). A case report of a female with a deletion in 13q12.2 seemed to provide further evidence of a critical locus in the 13q12.2-13 region ([@PATELMCS000984C35]). A reciprocal translocation t(1;2)(p22.3;q21.1) was identified in a male with a Moebius-like syndrome, presenting with bilateral facial nerve palsy, ptosis, anteverted nostrils, and malformed and low-set ears ([@PATELMCS000984C26]). Other chromosomal aberrations reported in rare cases include paracentric inversion of Chromosome 8 (inv(8) (q21.3q24.13)) ([@PATELMCS000984C15]) and complex chromosomal rearrangement t(7;8;11;13) ([@PATELMCS000984C3]). The three Moebius syndrome loci have been defined as *MBS1* (MIM 157900) at 13q12.2-q13 identified by [@PATELMCS000984C35], *MBS2* or *HCFP1* (hereditary congenital facial paresis 1) (MIM 601471) at 3q21-q22 after a report by [@PATELMCS000984C17], and *MBS3* or *HCFP2* (hereditary congenital facial paresis 2) (MIM 604185) at 10q21.3-q22.1 from a report by [@PATELMCS000984C43] of dominant Moebius syndrome in a Dutch family.

Despite numerous investigations, the molecular etiology of Moebius syndrome remains elusive. We performed an exome-sequencing study in a cohort of nine affected individuals because we hypothesized we could thus identify a commonly mutated gene. We describe an individual with a heterozygous de novo mutation in *TUBB3* diagnosed with "atypical" Moebius syndrome. His phenotype included bilateral ocular anomalies with near-complete ophthalmoplegia, agenesis of the corpus callosum, and absence of the septum pellucidum. We also describe the clinical features of our cohort of Moebius syndrome and report whole-exome-sequencing (WES) findings in our study cohort.

RESULTS {#s2}
=======

Clinical Description of Cohort {#s2a}
------------------------------

Our study cohort included three females and six males, predominantly of European and Hispanic ethnicity ascertained by clinicians of the Baylor College of Medicine from May 2009 to April 2014 (pictures in [Fig. 1](#PATELMCS000984F1){ref-type="fig"} and clinical details in [Table 1](#PATELMCS000984TB1){ref-type="table"}). Clinical details were compiled by the clinicians, and blood was drawn for DNA extraction.

![Pictures of the nine patients described in this manuscript: (*A*) individual 3, (*B*) individual 4, (*C*) individual 2, (*D*) individual 1, (*E*) individual 5, (*F*) individual 6, (*G*) individual 7, (*H*) individual 8, and (*I*) individual 9.](PatelMCS000984_F1){#PATELMCS000984F1}

###### 

Clinical features of patients enrolled for exome sequencing

  Family and patient number   [Figure 1](#PATELMCS000984F1){ref-type="fig"}   Ethnicity and gender    Typical/atypical Moebius syndrome   FH of Moebius                                 Cranial nerve palsy                                                                           Comments (cranial nerves)                                                                       Hypoplastic tongue   Feeding problems   Brain MRI abnormalities
  --------------------------- ----------------------------------------------- ----------------------- ----------------------------------- --------------------------------------------- --------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------- -------------------- ------------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1                           1D                                              Hispanic female         Typical                             Father has strabismus                         VI, VII                                                                                                                                                                                       \+                   \+                 Normally formed brain without any significant brain parenchymal abnormalities
  2                           1C                                              Hispanic male           Typical                             −                                             VI, VII                                                                                                                                                                                       \+                   \+                 Mild brainstem thinning, nonvisualization of the cisternal abducens and facial nerves
  3                           1A                                              Caucasian male          Typical                             −                                             VI, VII                                                                                                                                                                                       \+                   \+                 Absent bilateral cranial nerves VI and VII, absent facial colliculi, and pontine tegmental hypoplasia
  4                           1B                                              Hispanic male           Typical                             Mother has congenital left thumb hypoplasia   VI, VII                                                                                       Aberrant tearing, gaze palsy                                                                    Ankyloglossia        \+                 Diminutive pons
  5                           1E                                              Hispanic female         Typical                             −                                             VI, VII                                                                                                                                                                                       Unknown              Unknown            Within normal limits, right vertebral artery hypoplastic
  6                           1F                                              Hispanic male           Atypical                            −                                             All EOMs except the lateral rectus muscles, are nonfunctional, fibrotic, and thinner on MRI   Facial paralysis. Aberrant innervation of levator bilaterally with bilateral upper lid ptosis   −                    \+                 Agenesis of corpus callosum and septum pellucidum, hypoplastic olfactory nerves. The other cranial nerves including the optic nerve, fifth, sixth, seventh, and eighth nerves have a within normal limits appearance, mild splaying of the cerebral peduncles, concerning for mild brainstem hypoplasia, simplified gyral pattern
  7                           1G                                              Caucasian/Indian male   Atypical                            −                                             VI, VII                                                                                                                                                                                       Unknown              \+                 Not done
  8                           1h                                              Caucasian male          Atypical                            −                                             VI, VII                                                                                       Bilateral gaze palsy, decreased blinking rate, nasolacrimal duct obstruction                    \+                   \+                 Facial colliculi present within the brainstem, abducence nerves not well-defined in the prepontine cisterns
  9                           1I                                              Caucasian female        Typical                             −                                             VI, VII                                                                                                                                                                                       −                    \+                 Bilateral facial nerves unremarkable, normal caliber of the right cranial nerve VI is seen. No visualization of the left cranial nerve VI is identified. Left vertebral artery is hypoplastic.

  Family and patient number    Developmental delay/intellectual disability  Facial dysmorphisms                                                                                                                                                                          Short stature  Digits                                      Upper extremities                                                               Lower extremities                                                                                                                           Other anomalies
  --------------------------- --------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------- ------------------------------------------- ------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------
  1                                                \+                       Bilateral facial nerve palsy and abduction deficits, epicanthal folds, flat nasal bridge, anteverted nares, broad nose, small mouth and micrognathia                                               −        Truncation anomaly of lower extremity       Normal                                                                          Limb length discrepancy, oligodactyly with only two digits present likely fourth and fifth toes, with cutaneous syndactyly                  
  2                                                \+                       Bilateral epicanthal folds, eyes are directed inferonasally, low-set ears lacking lobules, bulbous nose, malar hypoplasia, small mandible, small mouth                                             −        Right fourth digit camptodactyly            Right upper extremity and chest wall smaller than the left, Poland\'s Anomaly   Clubfeet                                                                                                                                    
  3                                                \+                       Bilateral facial nerve palsy and abduction deficits, telecanthus, downslanting palpebral fissures, bilateral facial palsy, flat nasal bridge, hypoplastic alae nasi                               \+        Truncation anomaly of lower extremity       Normal                                                                          Truncation of lower extremity involving the right leg with complete absence of foot, also has club foot deformity involving the left foot   
  4                                                \+                       Flat facies, hemangioma of nasal root, bilateral facial nerve palsy and abduction deficits, telecanthus, wide nasal bridge, bulbous nasal tip, small mouth, tented upper lip micrognathia         \+        Oligodactyly                                Left hand has only two distinct digits                                          Bilateral talipes equinovarus                                                                                                               Patent foramen ovale; sensorineural hearing loss
  5                                                \+                       Facial asymmetry, bilateral abduction deficits, epicanthal folds, small mouth                                                                                                                      −        Left second, third, and fourth syndactyly   Left hand syndactyly with Poland anomaly                                        Normal                                                                                                                                      
  6                                                \+                       Flat facies, absent nasolabial folds, complete paresis of extraocular and facial muscles, downturned corners of the mouth, small jaw                                                               −        Normal                                      Normal                                                                          Normal                                                                                                                                      High hyperopia
  7                                                 −                       Decreased lateral and medial gaze,midface hypoplasia, small jaw                                                                                                                                    −        Normal                                      Normal                                                                          Normal                                                                                                                                      Submucosal cleft, atrial septal defect
  8                                                 −                       Facial asymmetry, midface hypoplasia, small jaw                                                                                                                                                   \+        Normal                                      Normal                                                                          Normal                                                                                                                                      
  9                                                \+                       Flat facies, tented open mouth                                                                                                                                                                     −        Normal                                      Normal                                                                          Bilateral talipes equinovarus                                                                                                               

Trio exomes (both parents and child) were conducted for families 1 and 3.

FH, family history; EOMs, extraocular muscles; MRI, magnetic resonance imaging; +, yes; --, no.

Unilateral or bilateral facial and abducens nerve palsies (sixth and seventh cranial nerves) were observed in all nine patients and was the eligibility criteria to be included in this study. Limb abnormalities were confirmed in 6/9 (66%) cases, seen as lower extremity truncating defects, oligodactyly, syndactyly, and/or talipes equinovarus. Poland anomaly, with ipsilateral aplasia or hypoplasia of the pectoralis muscle plus hand and digit anomalies, was present in 2/9 (22%) patients. No substantial limb/skeletal defects were identified in 3/9 patients (individuals 6, 7, and 8). Brain magnetic resonance imaging (MRI) studies were completed in 8/9 cases. Although many patients were noted to have defects of cranial nerves VI and VII on brain imaging, as typically seen in Moebius syndrome, patient 6 was found to have agenesis of corpus callosum, absent septum pellucidum, hypoplastic olfactory nerves, mild brainstem hypoplasia, and simplified gyral patterns. This patient also had atypical ocular findings with near-complete ophthalmoplegia. Two patients had magnetic resonance angiogram studies completed and were noted to have unilateral hypoplastic vertebral arteries (5 and 9).

Genetic Analyses {#s2b}
----------------

We first assessed novel and rare variants (minor allele frequency \[MAF\] \< 1% in population databases) present in known related disease genes. When comparing the phenotypes associated with the genes containing candidate rare or novel variants and the phenotypes of the patients in our cohort, we identified a mutation in *TUBB3* in patient 6 (g.Chr16:90,002,087(G\>A); NM_006086.3:c.1228G\>A; p.Glu410Lys). Trio analysis of proband 6 and his parents identified this mutation to be de novo in the affected patient ([Fig. 2](#PATELMCS000984F2){ref-type="fig"}). Subsequent polymerase chain reaction (PCR) amplification and Sanger sequencing of this variant confirmed the WES results. This mutation has been shown previously to cause congenital fibrosis of the extraocular muscles type 3 (CFEOM3A; MIM\# 600638), either isolated or in combination with other neurological disorders ([@PATELMCS000984C41]). A comparison between this condition, patient 6, and Moebius syndrome is shown in [Table 2](#PATELMCS000984TB2){ref-type="table"}.

![Exome sequencing revealed a mutation in *TUBB3*. Shown here is the Sanger confirmation and the exome-sequencing visualization of the de novo mutation identified in patient 6 in the gene *TUBB3* (g.Chr16:90,002,087(G\>A); NM_006086.3:c.1228G\>A; p.Glu410Lys).](PatelMCS000984_F2){#PATELMCS000984F2}

###### 

Comparison of disease features between Moebius syndrome, CDCBM/CFEOM3, and patient 6

                                        Moebius syndrome                                                                                             CDCBM/CFEOM3                                                *TUBB3* E410K phenotype                                                                                            Patient 6 with CFEOM3
  ------------------------------------- ------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene                                  Unknown                                                                                                      *TUBB3*                                                     *TUBB3*                                                                                                            *TUBB3*
  Inheritance                           Variable                                                                                                     De novo dominant                                            De novo dominant                                                                                                   De novo dominant
  Neurological                          Intellectual disability                                                                                      Intellectual disability, spasticity, axial hypotonia        Intellectual disability, Kallmann Syndrome, vocal cord paralysis, hypotonia                                        Intellectual disability
  MRI                                   Brainstem hypoplasia                                                                                         Thin corpus callosum                                        Thinning of corpus callosum, anterior commissure, and internal capsule, hypoplastic/absent olfactory sulci/bulbs   Agenesis of corpus callosum, absence of septum pellucidum; hypoplastic olfactory nerves; possible mild brainstem hypoplasia and simplified gyral pattern
  Ocular                                CN VI, VII, XII palsy                                                                                        Strabismus                                                  CN III, VII palsy                                                                                                  CN VII palsy, near-complete ophthalmoplegia, exotropia
  Skeletal ([@PATELMCS000984C19])       Clubfoot, syndactyly, brachydactyly                                                                          Short stature, wrist/finger contractures                    Short stature                                                                                                      Normal stature
  Craniofacial ([@PATELMCS000984C19])   Small palpebral fissures, epicanthal folds, hypertelorism, external ear defects, microstomia, micrognathia   Midface hypoplasia, short nose, short and smooth philtrum   Midface hypoplasia, short nose, short/smooth philtrum, low-set ears                                                Flat facies, absent nasolabial folds, downturned corners of the mouth, small jaw

CDCBM, cortical dysplasia complex with other brain malformations; CFEOM3, congenital fibrosis of the extraocular muscles; CN, cranial nerve.

Searching for common causative genes in the other families, we considered genes in the previously proposed Moebius loci and also analyzed shared genes with rare or novel variants. We focused on genes with rare or novel mutations in at least two affected individuals. Considering genes with a single novel or very rare heterozygous mutation in three individuals, four genes were identified: *HECW2, SIM1, BCDIN3D*, and *MRPL28* (details on all variants are shown in [Table 3](#PATELMCS000984TB3){ref-type="table"}). The variants in all genes were inherited from an unaffected parent, and were thus considered less likely to be involved in the disease. Considering genes with one single novel or very rare heterozygous mutation in two individuals, there were seven genes: *CDH11, KBTBD7, FAM71A, PLCB2, PTCH2, AMH*, and *HSPB7*. The variants were also inherited from an unaffected parent, and were thus considered less likely to be disease-causing. Of note, the analysis of rare shared variants in two or more individuals was confounded by the Hispanic ethnicity of some of the patients. Many of these shared variants were determined to be polymorphisms as verified in an ethnicity matched Hispanic control sample during variant confirmation and segregation. For the analyzed trios, we did not identify de novo variants occurring in genes shared by at least two individuals; candidate genes with de novo variants were *ADAMTS8*, *BSN, INTS6L, ZNF787, KDM6B*, and *NPIPA5*. We did not identify mutations in *PLXND1* and *REV3L* ([@PATELMCS000984C42]), although coverage for the first exon of *PLXND1* was incomplete because of high GC content. Although none of the genes with identified de novo variants replicated in other individuals, one variant that appears particularly interesting is a 12-bp deletion in *BSN* (Bassoon: NM_003458) in individual 9, which we confirmed to be de novo and which is predicted to be deleterious by bioinformatic algorithms like MutationTaster and PROVEAN (Protein Variation Effect Analyzer). Bassoon is a presynaptic scaffolding protein that seems to play an important role in cytoskeleton organization and recruitment of channels and other proteins relevant to presynaptic plasticity and regulated release of neurotransmitters ([@PATELMCS000984C16]; [@PATELMCS000984C8]). However, *BSN* is considered as a gene with frequent rare mutations in exome-sequencing studies ([@PATELMCS000984C34]), and this specific variant was found in the ExAC (Exome Aggregation Consortium) database (exac.broadinstitute.org) ([@PATELMCS000984C21]).

###### 

All variants referred to in the text

  Gene        Chromosome   HGVS coding DNA reference                  HGVS Protein Reference   Predicted effect         Variant type   dbSNP ID if available   Genotype       ClinVar ID   ClinVar submission accession   ExAC highest MAF   Inheritance
  ----------- ------------ ------------------------------------------ ------------------------ ------------------------ -------------- ----------------------- -------------- ------------ ------------------------------ ------------------ ---------------------------------
  *TUBB3*     16           NM_006086.3:c.1228G\>A                     NP_006077.2              p.(Glu410Lys)            Substitution   rs267607165             Heterozygous   6867         SCV000299173.1                 Not found          De novo
  *HECW2*     2            NM_020760.1:c.3394G\>A                     NP_065811.1              p.(Asp1132Asn)           Substitution   rs552109642             Heterozygous   254098       SCV000299174.1                 0.001911           Inherited from a healthy parent
  *HECW2*     2            NM_020760.1:c.2270_2272del                 NP_065811.1              p.(Glu757del)            Deletion       rs757981529             Heterozygous   254099       SCV000299175.1                 9.81E-05           Inherited from a healthy parent
  *HECW2*     2            NM_020760.1:c.1249_1251delAAT              NP_065811.1              p.(Asn417del)            Deletion       rs774571391             Heterozygous   254100       SCV000299176.1                 0.000864           Inherited from a healthy parent
  *SIM1*      6            NM_005068.2:c.2119G\>C                     NP_005059.2              p.(Asp707His)            Substitution   rs74726213              Heterozygous   254101       SCV000299177.1                 0.000854           Inherited from a healthy parent
  *SIM1*      6            NM_005068.2:c.1994G\>A                     NP_005059.2              p.(Arg665His)            Substitution   rs146866401             Heterozygous   254102       SCV000299178.1                 0.05045            Inherited from a healthy parent
  *BCDIN3D*   12           NM_181708.2:c.23A\>G                       NP_859059.1              p.(Asp8Gly)              Substitution   rs143608766             Heterozygous   254103       SCV000299179.1                 0.07137            Inherited from a healthy parent
  *MRPL28*    16           NM_006428.4:c.610G\>A                      NP_006419.2              p.(Val204Met)            Substitution   rs181590179             Heterozygous   254104       SCV000299180.1                 0.009075           Inherited from a healthy parent
  *MRPL28*    16           NM_006428.4:c.176G\>C                      NP_006419.2              p.(Arg59Pro)             Substitution   rs149440376             Heterozygous   254105       SCV000299181.1                 0.001542           Inherited from a healthy parent
  *CDH11*     16           NM_001797.2:c.95G\>A                       NP_001788.2              p.(Arg32Gln)             Substitution   rs757142171             Heterozygous   254106       SCV000299182.1                 Not found          Inherited from a healthy parent
  *CDH11*     16           NM_001797.2:c.1247C\>T                     NP_001788.2              p.(Pro416Leu)            Substitution   rs200234049             Heterozygous   254107       SCV000299183.1                 0.000867           Inherited from a healthy parent
  *KBTBD7*    13           NM_032138.4:c.1496C\>G                     NP_115514.2              p.(Pro499Arg)            Substitution   rs754048481             Heterozygous   254108       SCV000299184.1                 Not found          Inherited from a healthy parent
  *KBTBD7*    13           NM_032138.4:c.1208A\>C                     NP_115514.2              p.(Lys403Thr)            Substitution   rs748092018             Heterozygous   254109       SCV000299185.1                 0.000302           Inherited from a healthy parent
  *FAM71A*    1            NM_153606.3:c.1465T\>C                     NP_705834.2              p.(Ser489Pro)            Substitution   rs767737768             Heterozygous   254110       SCV000299186.1                 0.003196           Inherited from a healthy parent
  *FAM71A*    1            NM_153606.3:c.1475G\>A                     NP_705834.2              p.(Gly492Asp)            Substitution   rs886037883             Heterozygous   254111       SCV000299187.1                 Not found          Inherited from a healthy parent
  *PLCB2*     15           NM_004573.2:c.1154A\>G                     NP_004564.2              p.(Lys385Arg)            Substitution   rs769251460             Heterozygous   254112       SCV000299188.1                 1.56E-05           Inherited from a healthy parent
  *PLCB2*     15           NM_004573.2:c.2585C\>A                     NP_004564.2              p.(Thr862Lys)            Substitution   rs779256250             Heterozygous   254113       SCV000299189.1                 Not found          Inherited from a healthy parent
  *PTCH2*     1            NM_003738.4:c.2018G\>T                     NP_003729.3              p.(Arg673Leu)            Substitution   rs760548568             Heterozygous   254114       SCV000299190.1                 0.000347           Inherited from a healthy parent
  *PTCH2*     1            NM_003738.4:c.1156A\>T                     NP_003729.3              p.(Ile386Phe)            Substitution   rs775127172             Heterozygous   254115       SCV000299191.1                 8.64E-05           Inherited from a healthy parent
  *AMH*       19           NM_000479.3:c.350G\>A                      NP_000470.2              p.(Arg117Gln)            Substitution   rs185020288             Heterozygous   254116       SCV000299192.1                 0.01899            Inherited from a healthy parent
  *HSPB7*     1            NM_014424.4:c.442A\>G                      NP_055239.1              p.(Thr148Ala)            Substitution   rs530970423             Heterozygous   254117       SCV000299193.1                 0.01699            Inherited from a healthy parent
  *ADAMTS8*   11           NM_007037.4:c.2109C\>A                     NP_008968.4              p.(Tyr703\*)             Nonsense       rs199760382             Heterozygous   254118       SCV000299194.1                 0.01592            De novo
  *BSN*       3            NM_003458.3:c.7366\_ 7377delCAGCAGCTGCAG   NP_003449.2              p.(Gln2463_Leu2466del)   Deletion       rs759806020             Heterozygous   254119       SCV000299195.1                 0.000853           De novo
  *INTS6L*    X            NM_182540.4:c.352delT                      NP_872346.3              p.(Leu120\*)             Nonsense       rs782242788             Heterozygous   254120       SCV000299196.1                 Not found          De novo
  *ZNF787*    19           NM_001002836.2:c.1086G\>C                  NP_001002836.2           p.(Glu362Asp)            Substitution   rs202243737             Heterozygous   254121       SCV000299197.1                 0.000173           De novo
  *KDM6B*     17           NM_001080424.1:c.768_769insCCACCA          NP_001073893.1           p.(Pro263_Pro264dup)     Duplication    rs768799563             Heterozygous   254122       SCV000299198.1                 5.51E-05           De novo
  *NPIPA5*    16           XM_003118698.1:c.962C\>T                   XP_003118746.1           p.(Pro321Leu)            Substitution   rs886037884             Heterozygous   254123       SCV000299199.1                 Not found          De novo

HGVS, Human Genome Variation Society; dbSNP, Database for Short Genetic Variations; ExAC, Exome Aggregation Consortium; MAF, minor allele frequency.

DISCUSSION {#s3}
==========

Mutations in *TUBB3* are known to cause diseases such as CFEOM ([@PATELMCS000984C41]) and complex cortical dysplasia with other brain malformations type 1 (CDCBM1, MIM\# 614039) without major ocular findings ([@PATELMCS000984C27]).

Moebius syndrome and CFEOM are classified as cranial nerve dysinnervation disorders ([@PATELMCS000984C4]). CFEOM is characterized by bilateral blepharoptosis and ophthalmoplegia, with eyes infraducted at 20°--30° below the midline. Involvement of the horizontal extraocular muscles is variable. Bilateral involvement in all affected family members defines CFEOM1 (MIM\# 135700) and is caused by dominant mutations in *KIF21A* (type 1A) or *TUBB3* (type 1B). CFEOM2 (MIM\# 602078) is caused by recessive *PHOX2A* mutations and is characterized by congenital incomitant strabismus secondary to orbital dysinnervation. There are poorly reactive pupils, ptosis, large angle exotropia, and ophthalmoplegia. CFEOM3 shows phenotypic overlap with CFEOM1, but with more variability (e.g., unilateral involvement, ability to raise eyes above midline, no ptosis). CFEOM3 is autosomal dominant with mutations in *TUBB3* (type 3A, MIM\# 600638) or *KIF21A* (type 3B, MIM\# 135700).

[@PATELMCS000984C6] described a cohort of individuals with the E410K mutation in *TUBB3*, thus defining the "*TUBB3* E410K syndrome." The syndrome is characterized by CFEOM, facial weakness, Kallmann syndrome, vocal cord paralysis, tracheomalacia, and later-onset progressive sensorimotor polyneuropathy and cyclic vomiting ([@PATELMCS000984C6]). The affected individuals often have perturbed social, behavioral, and intellectual function. Brain imaging studies often demonstrate dysgenesis of the corpus callosum, anterior commissure, and internal capsule ([@PATELMCS000984C41]) and thin corpus callosum, hypoplastic or absent olfactory sulci/olfactory bulbs, and small or absent oculomotor and facial nerves ([@PATELMCS000984C6]). Patient 6, whom we describe with the E410K mutation, exhibited facial weakness and near-complete ophthalmoplegia. He was found to have agenesis of the corpus callosum, absence of the septum pellucidum, hypoplastic olfactory nerves, mild brainstem hypoplasia, and simplified gyral pattern, highlighting the variability of *TUBB3* mutations.

TUBB3 plays a role in axon guidance and normal brain development ([@PATELMCS000984C41]). The β-tubulins compose one of two core protein families (α- and β-tubulins) that heterodimerize to form microtubules. Microtubules perform essential functions especially during mitosis, intracellular transport, and both ciliary and flagellar motility. Mutations in *TUBB3* perturb microtubule structure and function, which lead to aberrations in axonal guidance and cortical organization ([@PATELMCS000984C27]; [@PATELMCS000984C41]; [@PATELMCS000984C6]). Functional studies of the E410K amino acid substitution indicate impaired tubulin dimerization and/or disruption of microtubule--kinesin interactions ([@PATELMCS000984C41]).

[@PATELMCS000984C27] further expanded the *TUBB3* mutation spectrum to include CDCBM1. Although no individuals in their cohort had the E410K mutation, features similar to the individual we describe were noted, such as hypoplastic corpus callosum, strabismus, and developmental delay. Other brain abnormalities included dysmorphic and hypertrophic basal ganglia structures, dysplasia of the cerebellar vermis, and hypoplastic brainstem. Interestingly, none of the individuals in this study presented with external opthalmoplegia or facial weakness. More severely affected individuals displayed global gyral disorganization, agenesis of corpus callosum, and cerebellar dysplasia. On the contrary, less severely affected individuals with mild intellectual disability presented with frontoparietal gyral disorganization, but without corpus callosum and basal ganglia involvement.

The expansion of *TUBB3*-related phenotypes may provide clues into the function of this gene. Individuals with the E410K mutation in TUBB3 have CFEOM but can also have a number of additional characteristics. Our cohort of atypical Moebius individuals had many overlapping features. Further study of *TUBB3* may help explain whether this mutation exhibits variable expressivity. Because these mutations can cause a phenotype resembling Moebius syndrome, clinicians should be aware of atypical presentations in the presence of classic facial weakness and ocular abnormalities. In our cohort, we considered findings such as agenesis of corpus callosum and septum pellucidum, hypoplastic olfactory nerves, brainstem hypoplasia, simplified gyral pattern, normal tongue, and normal development/intellect to be atypical of Moebius syndrome. Typical Moebius syndrome is classic for facial and abducens nerve palsy, orofacial malformations, and limb/chest wall abnormalities. The variation in the clinical findings makes the distinction between atypical and typical difficult. As more is learned about the spectrum of cranial nerve dysinnervation syndromes, the diagnosis criteria will hopefully become better defined. These investigations and reports will allow targeted management and guidance for individuals diagnosed with atypical Moebius syndrome.

The approach of WES did not identify a common genetic basis of Moebius syndrome in our study. The reasons could be multiple, such as technical artifacts in which our methods were unable to capture the coding regions of the responsible gene at all or sequencing was not achieved at a desirable coverage. Genetic heterogeneity, deletion of a single exon, mutations in a promoter region, deep intronic mutations, or other noncoding, nonexonic variants could be responsible for Moebius syndrome, as well as balanced translocations, which would be missed by the chromosome microarrays performed in a majority of the patients in our study. Epigenetic factors and other nongenetic or environmental events such as vascular disruption during gestation cannot be discarded. With the more common application and availability of genomic technologies and the data sharing among the scientific community of whole genomes and exomes of patients affected by rare disorders such as Moebius syndrome, we could begin to aggregate these data and dissect the possible causes for this significant disorder of as yet, unclear etiology.

METHODS {#s4}
=======

We performed whole-exome sequencing on peripheral blood DNA from all nine affected patients as described previously ([@PATELMCS000984C5]). Case--parent trios were completed for six of nine families: 1, 3, 6, 7, 8, and 9. Using 1 µg of DNA an Illumina paired-end precapture library was constructed according to the manufacturer\'s protocol (Illumina Multiplexing_SamplePrep_Guide_1005361_D) with modifications as described in the BCM-HGSC Illumina Barcoded Paired-End Capture Library Preparation protocol. Precaptured libraries were pooled and then hybridized in solution to either the HGSC VCRome design (42 Mb, NimbleGen) or the HGSC CORE design ([@PATELMCS000984C2]) (52 Mb, NimbleGen) according to the manufacturer\'s protocol NimbleGen SeqCap EZ Exome Library SR User\'s Guide (Version 2.2) with minor revisions. The sequencing run was performed in paired-end mode using the Illumina HiSeq 2000 platform, and with a sequencing yield of 10.3 Gb, the samples achieved 93% of the targeted exome bases covered to a depth of 20× or greater. Read mapping and alignment to the human genome reference assembly GRCh37 (hg19) was performed using the HGSC in-house developed Mercury pipeline ([@PATELMCS000984C29]) (<https://www.hgsc.bcm.edu/content/mercury>), achieving an average coverage of 116× read depth ([Supplemental Table 1](http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a000984/-/DC1)). Variant calling was performed using the Atlas2 ([@PATELMCS000984C32]) and SAMtools ([@PATELMCS000984C22]) algorithms. Variants were annotated using intramurally developed pipelines for their coding potential (exonic, intronic, or intragenic) and anticipated functional effects (synonymous, missense, frameshift, or nonsense variants), as well as their frequency in different population-scale databases such as the Database for Short Genetic Variations (dbSNP) ([@PATELMCS000984C33]), the 1000 Genomes Project ([@PATELMCS000984C39]), and the National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project ([@PATELMCS000984C11]). Novel and rare coding variants (MAF \< 1% in population databases) were preferentially explored in order to filter out common polymorphisms and high frequency, probably benign variants. Algorithms for bioinformatic prediction of functional effects of variants, such as PolyPhen-2 ([@PATELMCS000984C1]), SIFT ([@PATELMCS000984C20]), and MutationTaster ([@PATELMCS000984C31]), along with conservation scores GERP (Gene Evolutionary Rate Profiling) ([@PATELMCS000984C7]) and PhyloP and PhastCons ([@PATELMCS000984C13]), were incorporated as part of the variant annotation pipeline and used to inform the potential deleterious effects of identified candidate variants in order to prioritize them for additional functional testing. Candidate de novo variants and indels were inspected visually using the Integrative Genomics Viewer (IGV) in case--parent trios to discriminate false-positive calls ([@PATELMCS000984C40]). Candidate variants were PCR-amplified using specific primers for the exons containing the variants of interest and further confirmed by orthogonal Sanger sequencing of the PCR products. For Sanger sequencing, amplicons were generated with 0.5 ng/µL of genomic DNA and TaqMan polymerase (ABI, Life Technologies) by the manufacturer\'s protocol. Primers sequences are shown in [Supplemental Table 2](http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a000984/-/DC1). Products were sequenced at Beckman Coulter Genomics (Danvers, MA). In addition, a majority of the patients had a chromosomal microarray performed to rule out a chromosomal deletion or duplication (details in [Supplemental Table 3](http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a000984/-/DC1)).
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Data Deposition and Access {#s5a}
--------------------------

The families consented to the genetic study and the publication of genetic results, clinical details, and pictures. However, they did not specifically consent to the deposition of exome data in public repositories. The variants described in this study have been submitted to ClinVar (<https://www.ncbi.nlm.nih.gov/clinvar/>) under accession numbers SCV000299173.1 through SCV000299199.1 (see [Table 3](#PATELMCS000984TB3){ref-type="table"} for full list).
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